Healthcare Startups funded by Y Combinator (YC) 2024

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

We make oral drugs to treat and prevent viral infections - like COVID-19.

Clipboard Health exists to lift as many people up the socioeconomic ladder as possible. We dramatically improve lives by letting healthcare professionals turn extra time and ambition into career growth and financial opportunity. We achieve this with our app-based marketplace that connects healthcare facilities and healthcare professionals, allowing healthcare professionals to book on-demand shifts and healthcare facilities to access on-demand talent. Our mission is to enable healthcare professionals to work when and where they want and to enable healthcare facilities to meet their talent needs. Clipboard Health is a fast-growing Series C startup with classic two-sided network effects. We have product-market fit, generate substantial revenue, and we are helping nurses fix healthcare one shift at a time. Clipboard Health is a diverse and inclusive company with a global, remote-first team of hundreds of people. We’ve been featured on YC’s Top Companies and grown our revenue 25x in the last 18 months. We need your help to keep growing so we can serve more healthcare professionals, healthcare facilities, and patients.

Alzheimer’s is tough. And while there is no cure, getting help should be 100x easier than it is today. We’ve raised over $6 million to solve that problem. When someone is going through the disease, there are many different things they need help with (i.e. memory issues, depression, fall risk, safety in the home, etc). The primary person responsible for that care is one of the patient’s loved ones – usually a child or a spouse. That’s a really difficult thing for the loved one to do. It’s stressful, time consuming, and difficult. If we can make their lives easier, we can not only improve their experience but also create better patient outcomes. We’re building the world’s first one-stop-shop, d2c care platform for Alzheimer’s, starting by optimizing the care monitoring, management, and intervention processes.

TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.

Andy is AI software that completes documentation for nurses doing home visits. Our software saves $8B a year; Tiantian was previously a PM at Google’s healthcare business and Max was a staff engineer on the health team at Apple. Andy benefits nurses and the agencies that employ them. Agencies that use Andy see up to 45% more detailed charts, 2x greater nurse productivity, and timely submission (no more billing delays!) With Andy, clinicians get their evenings back. Home health is the fastest growing segment of healthcare, doubling to $251B by 2031. Combined with recent nursing shortages and burnout, we’re seeing not just urgency, but excitement and joy, around adopting AI for home health.

Stealth-mode, rapidly scaling, venture-backed startup at the vanguard of automated robotic surgery revolution -- just closed our Series A round. We are improving access to dental care in underserved populations by combining novel imaging technology with AI and surgical robotics to automate surgery in the $452B dental industry. We are bringing a new imaging modality to dentistry which can see inside teeth and below the gingiva all without the need for x-rays. AI is used to diagnose decay and plan treatment. Automated robotics reduces the time for surgery down to one minute, reducing patient discomfort and saving time and reducing cost for the dentist. YC 2020, Winner of the Forsyth DenTech 2021 CareCaptial award

Fortuna is a one-stop solution that helps consumers navigate Medicaid end-to-end from eligibility and enrollment to renewing coverage. Our platform creates value as the middleware layer for the $800B Medicaid ecosystem.

Fella Health is the telehealth clinic for men with obesity. With Fella, patients meet a board-certified obesity doctor to prescribe FDA-approved medications, while they undertake personalized health coaching through our app.

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Our device catheter-based device is able to safely perform a targeted nerve ablation in the upper abdomen. Cardiologists are concerned about collateral tissue damage in ablation procedures - our probe not only targets a very specific area, but also confirms that it’s done correctly.

Archform is teeth aligner software startup that lets orthodontists create, design and 3D print aligners within their own offices. The idea is to provide orthodontists with a way to better compete against some direct-to-consumer teeth aligner startups and cut down on the cost of Invisalign.

Pre-clinical results published in the Journal of Neuro-Interventional Surgery. Technology presented at the World Live Neurovascular Conference. Technology selected as a top 3 finalist for Innovator of the Year by the Congress of Neurological Surgeons. Raised a Series A to fund commercialization (FDA Clearance, Health Canada, ISO 13485, First-in-man and early revenue).

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

Phoenix is a mission-driven digital healthcare platform for men. We are dedicated to improving the relationship men have with their health, while building the future of patient-centric healthcare in Canada from diagnosing to delivery.

Sohar Health is a SaaS platform for behavioral health companies. It is an API-based solution that offers >90% accurate eligibility verification, and AI-powered Verification of Benefits to automate manual workflows, increase patient intake, and generate more revenue. We focus particularly on high payer-by-payer accuracy (>90%), identification of payer carve outs (>90%), and high rate of automation (>95%). Our customers include Talkiatry, Mindful Health Solutions, Monument, LunaJoy (YC W22), Finni Health ( YC W23), Legion Health (YC S21), and Stellar Sleep (YC S23).

Still in stealth. Reach out to learn more! Backed by Y Combinator, Foundation Capital, Soma Capital, & Capital X.

Mytos builds machines that automate the growing of human cells for biotech and pharma companies. Our machines sit on-prem at customer sites, growing cells which they use for testing during early-stage drug development. Even though testing on cells is so critical for developing new drugs, today they're all grown totally manually, the same as 100 years ago! With our machines, for the first time our customers can hands-off manipulate and monitor batches of cells from the cloud. We've already working with some of the biggest pharma companies. Mytos has the opportunity to change the way the entire industry works - join us and help us get there!

There are over 70 million low accuracy tests done in US every year for conditions like the flu. Labsimply is using novel CRISPR enzymes to replace these with Point-of-care tests that offer PCR accuracy in 5 minutes or less.

We build wearable fetal health monitors. As parents, we want to know more about our babies. But it’s hard to believe that, despite all the technology available, we still do not know our baby without a visit to the doctor or hospitals. Which is time consuming, expensive, and stressful. That’s why we created Modoo. Mothers simply wear the device on their belly. It tracks baby’s heart rate, movements and generates baby’s health report, so we can consult a physician with just one click. Modoo connects to an app that allows users to share data via social media sites like WeChat and Weibo, which makes it easy to help family and friends feel more connected. And thanks to the information it collects, our users reported that, it has helped preventing the loss of 73 babies so far. We has been selling Modoo in China at price of 200 dollars since 2017. last year, we tripled our revenue to 3.4 million dollars. To target at a bigger market, we launched a subscription trial 3 months ago, with an initial price of 60 dollars. It’s growing 69% week on week, and already generating 50 thousand dollars in MRR. Pregnancy is a lucrative market. 16 million babies are born in China every year, that’s a $3.2 billion dollars home market. Worldwide 140 million births make a 28 billion dollars market. About us, Jiliang is the no.1 employee in an AI startup backed by Google & Sequoia. Ying, the CTO has over 20 years experience in mobile tech with some of the world’s leading companies. To sum up, we are Modoo, the wearable fetal heath monitor company. We tripled our revenue to 3.4 million dollars in 2018. And are testing subscription model with 69% weekly growth. We started in China with a 3.2 billion market and is unlocking a 28B dollars market worldwide.

We’re building technology to finance universal healthcare by crowdfunding surgeries and providing coverage for primary care.

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for half the price.

Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

Kivo Health provides telehealth rehab for chronic lung disease patients. We offer an 8-week clinical program led by a live therapist, which saves payers $6,000 per patient. Only 3% of eligible patients are getting this life-changing therapy right now.

KemNet supplies pharmacies with premium reformulations of popular drugs that are more useful for specific groups of patients. For example, more than 30 pharmacies rely on KemNet to supply reformulated products for erectile dysfunction that work up to 8 times faster than alternatives. In addition to sexual function, products reformulated for novel drug delivery and supplied on KemNet include medications for hair growth, pain, weight loss and women's health.

Redcliffe Labs (a unit of Redcliffe Lifetech Inc) provides diagnostics with a comprehensive portfolio approach both with routine and specialised test menus with advanced testing labs all over India. Its digital first approach with on-demand 1-hour home collection and same day report is disrupting the way diagnostics is delivered today and thus is the fastest growing in India. Redcliffe Labs is providing 3500+ tests across its wide network of labs and collection centres. The company has served about millions of Indians and is processing more than 250K+ test parameters daily. The test portfolio is very wide including routine pathology tests, advanced genetic screening, research-based DNA tests in reproductive health, cancer and wellness/fitness. The easy to interpret smart reports provide key health check-points, which can help in diagnosing and treating both chronic and acute diseases on time. Redcliffe Labs has pioneered Drone technology adoption in the diagnostic sector by opening up the first commercial corridor from Uttarkashi to Dehradun. The company currently has 30+ labs and 700+ authorised collection centres in more than 120 cities across India. Redcliffe's vision is to provide world-class diagnostic services to people across the Indian sub-continent in an affordable manner.

We are developing a new paradigm for consumer health tech wearables by replacing a 100lb optical instrument with an area of silicon smaller than a postage stamp.

Neodocs lets you perform instant lab tests on your smartphone. Our users are health optimizers and athletes who want to improve key nutritional markers for better performance. You simply collect your sample, take a picture, and results are instantly generated. We are the perfect team to build this. Anurag is a 3-time medical entrepreneur who’s built medical devices, Pratik has worked on AI/ML models for leading US banks, and Nikunj comes from a consulting background at Bain & Co. We’re building your personal lab on your phone.

Bemlo empowers healthcare organizations to offer their employees the flexibility they require. Did you know that the US will be 4 million healthcare workers short by 2026? Post-COVID, a record number of professionals have left the industry due to burnout and 3/10 are considering leaving. We increase retention by making it possible for nurses and doctors to work on their terms - without having to go through staffing agencies. Our customers post vacant shifts to their own pools as well as our marketplace of vetted professionals increasing fill rates while keeping expenses manageable. We serve healthcare organizations from single private elder care homes to large public regional healthcare systems with multiple hospitals and thousands of staff.

Rev Genomics is a plant biotechnology company that provides breeders, growers, and retailers with novel cultivars to differentiate themselves in high value markets.

Zeit Medical leverages the power of AI and wearable sensors to deliver peace of mind for those affected by stroke. Zeit’s smart headband immediately detects the onset of stroke and notifies 911. Each year more than 90% of the one million strokes in the US go untreated, resulting in life-long disability and exploding medical costs north of $100b. The lack of timely treatment is the result of delays in alerting the emergency services. More than 10 million Americans with an elevated stroke risk live with constant fear that a stroke may go unnoticed for hours, while they are asleep or alone. The company was founded by Orestis Vardoulis PhD a biomedical & mechanical engineer and expert in digital health (EPFL/Stanford) and Urs Naber MD a critical care physician (Dartmouth/Stanford). They have both seen the devastating effects of stroke in their families and came up with the idea of addressing this unmet clinical need during their Stanford Biodesign Innovation Fellowship.

Over 80% of maternal mortalities were preventable with earlier intervention. Currently, doctors miss >50% of moms who have life-threatening complications and wait until labor to start doing manual risk assessments, at which point it's too late. Elythea's proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. We automatically analyze relevant demographic and clinical risk factors, flag high-risk patients, and provide evidence-based interventions, giving doctors months in advance to intervene and prevent complications from ever happening. Our global clinical studies have shown that we can catch 2-3x more complications than clinical judgment 10x sooner.

Memora Health helps healthcare organizations digitize and automate complex care workflows, making them simple for patients and clinicians to navigate. Memora ingests existing data on clinical workflows, converts them into cohesive messaging journeys that guide patients through their care episodes, and automates the completion of simple follow-up tasks in the EMR. Memora's platform reduces care team notifications by nearly 40%, has a >70 average NPS, and has improved clinical outcomes across various populations. Contact us at info@memorahealth.com

We make it easy for anyone in India to access healthcare over Zoom, Meet, or WhatsApp. We provide care in 11 local languages. For every appointment, we provide a concierge who manages all logistics for the patient & handles the back-office work for doctors. With this, we have cracked the code to make telehealth work in India.

Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.

Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.

Our mission is to improve quality of life for millions of people by providing easy, immediate access to the world’s best sleep care. Sleep Reset is a digital, personalized sleep clinic, available in a convenient mobile app for iOS and Android. Our program was designed in partnership with leading sleep experts from top sleep clinics and universities. The program improves sleep and reduces sleep anxiety with the most effective methods from sleep clinics, including strategies based on Cognitive Behavioral Therapy for Insomnia (CBT-i) which are proven to be more effective than sleeping pills. Throughout our program, each member is paired with a dedicated sleep coach who personalizes their program. It’s a life-long, sustainable solution to sleep better in weeks, with no pills or melatonin needed – which means no grogginess, side effects, or dependency. Sleep Reset has been covered in Forbes, TechCrunch, and INSIDER. The company was founded by Yunha Kim, a serial entrepreneur recognized by Forbes as 30 Under 30 and is backed by top Silicon Valley investors including YCombinator, Foundation Capital, New Enterprise Associates, Stanford University and 20+ founders/executives of leading companies.

We provide high quality data for AI radiology. We're building the biggest database of labeled medical data in the world, starting with radiology images. We sell to medical companies who are training and validating AI algorithms.

ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Our proprietary (nanoparticle-free) technology, which we call ‘STAmP’, stabilizes the mRNA and utilizes an interchangeable, lock-and-key-like targeting mechanism which enables fully customizable mRNA medicines.

LifestyleRx delivers insurance-covered virtual care for Type 2 Diabetes reversal. Our doctors guide patients through lifestyle changes to reverse the underlying process of diabetes.

**TL;DR:** Legacy (YC S19) is a startup focused on the fast-growing field of fertility and family planning. Founded at Harvard, the company has now raised $40M from leading investors like FirstMark Capital, Bain Capital Ventures, Section 32, Tribe Capital, and even celebrities like Justin Bieber, The Weeknd, and others. **What we're doing** We aim to change the outdated view that fertility is a "women's issue" by creating an accessible, affordable product for men & people with sperm. This includes everything from a mail-in kit for sperm testing & sperm freezing, personalized sperm improvement products, tele-health, DNA fragmentation analysis, supplements, and more. **Why are we the leader?** The company was founded at Harvard by a team of healthcare and fertility experts. We obsess about talent density and have out-executed our competitors over the past few years. Beyond our D2C channel, we've also unlocked: 1. Nationwide insurance coverage (10M+ lives) 2. Military contracts (Including the Navy SEALs and 15M+ veterans) 3. Employer offerings (Working with the top fertility benefit providers) **Tell me about the team** We're a team of about 30, extremely diverse (majority female, majority immigrants, strong LGBQTIA+ representation, age range of 25-65), and very values driven. Our 5 values are customer centricity, reliability, kindness, openness, and winning. Learn more about our values here: https://khaled-legacy.medium.com/legacys-values-and-why-they-matter-db116539d3da Learn more about our workplace here: https://khaled-legacy.medium.com/how-and-why-legacy-is-reinventing-workplace-benefits-9e5fda6cb863 Read about our mission to humanize the path to parenthood: https://khaled-legacy.medium.com/how-and-why-legacy-is-reinventing-workplace-benefits-9e5fda6cb863 Learn more about sperm and why it matters here: docsend.com/view/zkgk7ws

Loop Health is a new type of healthcare provider in India combining high-quality primary care and insurance for employers. Employees get unlimited primary care visits at our asset-light clinics, alongside traditional hospitalization insurance. During YC, we grew from 0 to $85,000 ARR with 200% MoM growth. We serve 22 companies and 5500 members across Pune. Employers pay us $15/member/year and we make an additional $25 on prescriptions, lab tests, and hospitalization referrals. Our total gross margins are 70%. 200MM Indians are covered with employer-funded health insurance, representing a $8 billion dollar market opportunity, growing at 27% CAGR. Indian employers are dissatisfied with their health benefits today because insurance in India only covers hospital stays, not doctor visits – and only 8% of their employees will ever use the benefit in the year. With Loop, employers can offer a more engaging health benefit that includes doctor visits and telemedicine, alongside traditional hospital coverage, for about the same price. Because their employees have better access to doctors, we can also offer lower insurance premiums.

Empirical Health is proactive primary care. We use AI to triage healthcare resources to efficiently manage chronic illness and succeed in value-based care payment models. We're licensed, registered, and insured to deliver real medical care in 8 US states.

AlemHealth connects hospitals and diagnostic centres in emerging markets to a global network of diagnostic imaging services. Our suite of plug-and-play radiology solutions makes it easy for any facility anywhere to access and provide world-class diagnostic care to its patients. We designed our hardware and software from the ground up specifically for emerging markets, where access to internet, electricity, and clinicians can be difficult. Learn more about our solutions at www.alemhealth.com.

Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.

Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data. That's why we started Opentrons. We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions.

We empower mental healthcare clients with virtual reality sessions that are additive to traditional therapy. Clients regain their self-reliance the moment they are given the chance to contribute to their treatment. Therapists can focus on the aspects of treatment that e-health is not equiped to deal with. Treatment efficiency goes up - costs go down: E-health the way it was meant to be.

What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematology: * Our hemophilia network covers 33% of all patients and providers in the US. * We bested 20+ competitors, including several Fortune 500 companies. * Our clients include: Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.

Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.

Kingdom Supercultures designs novel microbial cultures that make it easy for food manufacturers to create exciting new foods. We've developed the world's first 0-calorie fermented sodas, beers with entirely new flavors, and novel plant-based dairy replacements.

ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications. They launched the world's first genetically engineered probiotic in 2019 – a probiotic that breaks down a toxic byproduct of alcohol. They are currently developing a pipeline of additional engineered probiotics for other consumer health applications.

Building a standard-of-care medical device to freeze abnormal cells before they become cervical cancer, in any clinic, anywhere in the world, at 1/10 the cost. -- Ananya Health is building a portable cryoablation unit designed for every primary care clinic in the world. Our beachhead application is cervical cancer prevention -- even though cervical cancer is easy to screen for, 80% of clinics worldwide lack the infrastructure and specialized staff to treat at the earliest stages. Our platform technology allows nurses and lower level health workers to treat at the point of care for 1/10 the cost of traditional ablation, and is the only cryo device that will help us achieve the WHO target to eliminate cervical cancer in our lifetime.

Ally helps people to manage their environmental allergies. With Ally, people can discover what they are allergic to and determine the best care plan. It all starts with our At-home allergy test. We send it to your home, and with a prick of blood, our labs learn what you are allergic to. This then personalizes the Ally app, which helps you track and manage your allergies. For example, you can know which days are worse based on location and symptoms. Ally acts as an AI-powered allergies coach. You can also learn from a community of other people with similar allergies what works best for them.

Nectome is a neuroscience startup that aims to preserve the brain and keep all its memories intact. The company is building the next generation of tools to preserve the connectome. The connectome is all the connections called synapses between neurons in the brain. Researchers from the company is now learning to manipulate individual memories, building advanced brain prosthetics, and reverse-engineering the brain.

GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. Our team is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities—creating novel therapeutics at an unprecedented pace. Our AI platform has enabled us to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Our AI platform enables tremendous pace and capital efficiency as demonstrated by our progress in ~2 years with seed capital—a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. The team at GEn1E has decades of experience in drug development and machine learning. We graduated from YCombinator and Stanford-StartX in late 2019. We are based in Palo Alto, CA.

If we've learned anything in the last few years it's that spending time with our friends and family is essential to our well-being and happiness. Unfortunately, loud and noisy places like weddings and family gatherings hinder human connection, especially for the hearing impaired. In fact, the biggest unmet need in the entire hearing healthcare industry is hearing in noisy places. AudioFocus helps patients hear in these environments by only enhancing voices nearby the patients and ignoring ones farther away. We do this using acoustics informed machine learning and custom microphone array design. Our goal is to increase the adoption rate of 37M US adults with hearing loss, only 8M use hearing aids today. Founded by Auditory Neuroscientist & AI expert and a Hearing Aid hardware design expert.

We are solving clinician staffing shortages for hospitals by automating routine patient-facing tasks.

MICSI is introducing AI software that doubles resolution and halves scan time. This breakthrough enables imaging centers to significantly enhance their capacity and patient throughput, potentially saving countless lives and generating an additional $2 million of revenue per MRI scanner. Our initial offering serves as a stepping stone toward the company’s larger vision of transforming the MRI into a truly quantitative instrument that is capable of providing highly reproducible data for more accurate diagnoses and patient management.

We empower clinicians with our AI platform for developing differential diagnoses and drafting clinical plans.

Agapé is a relationship wellness app that helps you feel close to your friends, family, or partner, even when apart! We curate daily questions to spark meaningful conversations for over 2 million people around the world.

Legion Health is a pioneering telepsychiatry company dedicated to transforming patient care through advanced technology. We leverage cutting-edge language models and robust data analytics to enhance our patient-provider interactions, improve access to mental health services, and streamline our clinical operations. Our mission is to integrate innovative AI solutions into every facet of psychiatric care, ensuring providers and patients benefit from the most effective and efficient treatment strategies.

Today's funders are so conservative they only fund the most obvious ideas. At Experiment, we fund the ideas that they won't fund; the ideas that matter. Since founding, over 47,000 citizens have pledged $9 million dollars supporting 900 scientific projects on the platform. 46% of all projects on Experiment are successfully funded. When the projects are finished, the scientists share the scientific results with their backers as lab notes and peer-reviewed publications. Scientists from Stanford, Harvard, and Yale have chosen to use Experiment instead of writing grants. Bill Gates recognized Experiment by saying "this solution helps close the gap for potentially-promising but unfunded projects."

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!

We build AI models to create novel, high performing biomolecules faster. Our AI models simulate the biophysical properties of biomolecules and identify the most promising ones to be tested in the lab.

Shiok Meats is a cell-based clean meat company, exclusively working on seafood. Shiok Meats is the first cell-based meat company in Singapore and SE Asia and we employ cellular agriculture to grow seafood meat in the laboratory using cells instead of animals. Shiok in Singapore English slang means fantastic and enjoyable. Our meats are animal-, health- and environment-friendly with the same taste, texture and nutrients, but no cruelty. Our mission is to bring delicious and healthy meat by harvesting from cells instead of animals.

Full Sleep by Koko Labs is the first at-home sleep program that combines the power of clinical grade, radar based wireless sleep tracking with best-in-class CBT-I sleep techniques. Full Sleep delivers daily lessons developed with evidence-based principles. The multi-week curriculum is customized based on your daily overnight sleep data and other health conditions that could impact sleep, such as menopause, chronic pain, or depression. Learn how to challenge assumptions, change habits, and introduce behaviors to help you fall and stay asleep.

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Miracle puts Clinical Operations in control. For biotech/pharma companies, Miracle is the "control room" for clinical trial management. Miracle helps save time by integrating vendor reports and trial data sources (i.e. EDC, IRT, study website) into a unified, real-time portal with actionable insights. Today, Miracle is powering a number of clinical trials around the world.

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

Patients enter their insurance and visit reason, and we use machine learning to predict and guarantee their out-of-pocket costs for every health provider. For health providers, we ensure their patients always pay the bill.

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

We provide free digital mental health technologies for millions of people struggling online — particularly young people. For example, we partner with online communities to help find and treat at-risk individuals directly on their platform using our online interventions.

We’re on a mission to make behavioral health more available and accessible. We're backed by a16z, YCombinator, Craft, and many others to make this dream a reality. At Juniper, we build software for behavioral health clinicians to improve quality of care. We streamline and replace manual efforts so clinicians can focus on what they do best: providing high-quality care. — Behavioral health is broken. We think this is a problem worth solving, and we think we know how to solve it. Interested? Check out https://jobs.lever.co/juniperplatform. — Want to say hi? Drop us a line at hello@juniperplatform.com.

Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.

Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).

Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.

Quadrant Eye is on a mission to improve eyecare access and fight preventable blindness. We're building the next generation eye exam... inside the average American home. Our team wants to enable patients' best and most visually rich lives. To this end, we're looking for curious and nimble minds to help us develop the world's first fully online eye exam and ultimately deliver high-quality eyecare at scale. Some QE highlights: 🐝 We're a team of surgeons, scientists, venture partners, and hackers who mean business. 💸 Our backers include Y Combinator, Khosla Ventures, and the creator of Google Image Search. 🍥 We're a mission-driven company tackling an eye health market worth $USD137B. 🌟 Our core focus is currently the development of patentable deep tech, and our overall vision is to change eyecare for good.

Oto’s digital programs are the best way to manage tinnitus, and at a fraction of the cost of in person treatment. Tinnitus or ringing in the ears affects 1 in 8 people, and before Oto effective therapy was only available via expensive meetings with a specialist.

YourChoice Therapeutics is revolutionizing the global contraceptive market. Our vision is to develop non-hormonal contraceptives to provide both women and men with birth control options that lack the associated risks of hormone-based options but are equally effective. Traditionally, it has been the women’s financial and health burden to have a contraceptive in place. Our first goal is therefore to bring a novel non-hormonal, on-demand and low cost female contraceptive to the market that will substantially improve their quality of life and well-being. Our second goal is to develop the first ever non-surgical and highly effective non-hormonal contraceptive for men. Currently, male contraception is limited to two main options – vasectomy or condoms. Having such options available to both women and men will globally allow for much better family planning, reduce the number of unwanted pregnancies including abortions and therefore reduce costs and ensure contraceptive health and well-being.

Fitia is an automated meal planner and nutrition tracker for weight loss or muscle gain. Our users get personalized recipes based on their data and their local country ingredients, supported with an exclusive database of 1M foods & recipes.

Adoption of Telehealth 1.0 has dropped to <5% because it's inefficient and unintelligent. Ankr uses generative AI to recreate functions of clinic staff including front desk, medical assistants and scribe. This allows Doctors to "spin-up" virtual clinics on-demand, anytime, anywhere. An average clinic using Ankr generates $1M in new revenue/year. We integrate with all top EHRs and work with all types of clinics in mid- to large-sized healthcare organizations.

We help healthcare companies run their practices. Eligibility, BI, claims, patient payments? Shoot us an email at founders@aperohealth.com Apero is a Y-Combinator-backed startup based in San Francisco bringing transparency and ease to medical billing. As one of the top startups from the Summer 2019 Y Combinator batch, we have raised from well-known investors including the creator of Gmail Paul Buchheit and the founders of Doctor on Demand, Gusto and Reddit, and serve startups that have raised over $1B in Venture Capital. The founding team are Stanford CS and Berkeley grads and include the CTO of Doctor on Demand having helped raised $240m and process millions of video calls. We are also hiring for engineers and product-minded operations people interested in giving price transparency to patients and providers. We serve practices nationwide, and integrate with leading EHRs as well.

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Pair Team cares for the highest-need Medicaid recipients through a community-led, virtual care model. We take responsibility for the whole person by addressing not just clinical needs, but also health-related social needs such as housing instability and food access. We partner with local community-based organizations like shelters and safety net providers to coordinate care alongside our multidisciplinary care team to improve the wellbeing of underserved individuals and communities.

Axle Health provides scheduling and workforce management software for home healthcare providers. The Axle platform includes a mobile app for clinicians, an operations dashboard for office teams, proprietary logistics algorithms to optimize scheduling, and a patient engagement and booking solution. Axle is integrated with a wide range of EMRs, and the entire Axle product can be customized and accessed modularly via API. Some of the biggest home health care providers in the country use Axle’s software to improve the utilization of their clinical teams, and automate the operational burden of scheduling and dispatching.

Rinse is building the One Medical for dental. Beautiful studios, easy to book same day appointments, and anxiety-free care focused on prevention, not the upsell.

We’re on a mission to leverage AI and voice technology to solve inefficiencies and revenue leakage in our healthcare system. With the rise of EHRs, the manual documentation burden on doctors has never been higher, leading to burnout and fatigue and high attrition rates. Assigning the correct diagnosis and billing codes is crucial for proper reimbursement and patient care, but medical coding is becoming more and more complex each year with growing numbers of codes (over 145,000 now), and doctors are unsupported by current technology to keep up with its ever increasing requirements. $125 billion is left on the table each year by healthcare organizations due to improper documentation and coding. Knowtex creates visit notes with up-to-date and accurate reimbursement codes from doctor-patient conversations, allowing the doctor to focus on patient care and preventing revenue leakage for hospital systems through standardized, transparent, and accurate documentation.

MedMe Health builds software for pharmacists to deliver paid clinical services like prescribing/adapting medications, point-of-care testing, giving vaccinations, and monitoring chronic conditions. Our web-based platform helps both independent pharmacies and large chains schedule appointments online, conduct virtual care, automate documentation, and flag clinical opportunities. With MedMe, our customers have increased their efficiency of clinical service delivery by 10x and increased pharmacy revenue with the same staff. For the first time, MedMe enables integrations to traditionally locally-stored pharmacy data. Our vision is to transform today’s dispensing locations to tomorrow’s health hubs.